Amundi
RGEN icon

Amundi’s Repligen RGEN Stock Holding History

Amundi’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3M Buy
44,959
+2,925
+7% +$409K ﹤0.01% 975
2025
Q4 		$6.89M Buy
42,034
+37,409
+809% +$5.86M ﹤0.01% 982
2025
Q3 		$694K Sell
4,625
-296
-6% -$36K ﹤0.01% 1241
2025
Q2 		$625K Sell
4,921
-80,376
-94% -$10.2M ﹤0.01% 1320
2025
Q1 		$10.4M Sell
85,297
-566
-0.7% -$87.1K ﹤0.01% 826
2024
Q4 		$13.3M Buy
85,863
+8,790
+11% +$1.26M ﹤0.01% 798
2024
Q3 		$10.4M Sell
77,073
-125,022
-62% -$17.9M ﹤0.01% 841
2024
Q2 		$24.4M Sell
202,095
-33,150
-14% -$5.2M 0.01% 668
2024
Q1 		$36.9M Sell
235,245
-131,907
-36% -$25.1M 0.02% 586
2023
Q4 		$63.6M Buy
367,152
+367
+0.1% +$57.1K 0.03% 484
2023
Q3 		$56M Buy
366,785
+43,840
+14% +$7.17M 0.03% 487
2023
Q2 		$45.9M Buy
322,945
+111,625
+53% +$17.9M 0.02% 527
2023
Q1 		$34.1M Buy
211,320
+20,848
+11% +$3.72M 0.02% 599
2022
Q4 		$33.8M Buy
190,472
+133,419
+234% +$24.2M 0.02% 583
2022
Q3 		$12.6M Buy
+57,053
New +$12M 0.01% 794
2022
Q2 		– Sell
-2,708
Closed -$490K – 1705
2022
Q1 		$490K Sell
2,708
-603
-18% -$115K ﹤0.01% 1295
2021
Q4 		$634K Hold
3,311
– – ﹤0.01% 1364
2021
Q3 		$957K Buy
3,311
+2,611
+373% +$670K ﹤0.01% 1297
2021
Q2 		$140K Buy
+700
New +$136K ﹤0.01% 1440

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Amundi's RGEN Position: Q1 2026 in Review

Amundi increased its Repligen (RGEN) stake by 7% in Q1 2026, buying an estimated $409K and bringing the position to 44,959 shares worth $5.3M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Amundi first reported a position in RGEN in Q2 2021 and has held it in 19 quarters since. The position peaked at $63.6M in Q4 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Amundi held 44,959 shares of Repligen worth $5.3M as of Q1 2026.
  • Amundi bought 2,925 Repligen shares in Q1 2026, an estimated $409K.
  • Repligen made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #975 holding.
  • Amundi first reported a position in Repligen in Q2 2021 and has held it in 19 quarters since.
  • Amundi's Repligen position peaked at $63.6M in Q4 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.